← Leaderboards
Rose Marie Viscardi
University Of Maryland Baltimore
$8,090,191
Attributed
$16,588,482
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2007–23$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$16,588,482 · 10
By mechanism
R01$9,503,337 · 4
U24$4,529,394 · 1
R41$958,192 · 2
R21$919,020 · 2
R34$678,539 · 1
Top collaborators
- Michael L. Terrin13 shared
- Namasivayam Ambalavanan6 shared
- Pamela Donohue6 shared
- David A Kaufman6 shared
- Ken B Waites6 shared
- Achsah D. Keegan5 shared
- Robert Lewis Schelonka5 shared
- Stefanie N. Vogel5 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Pamela Donohue$436,784
- David A Kaufman$436,784
- Alessio Fasano$18,889,816
- Stefanie N. Vogel$26,533,913
- Achsah D. Keegan$11,546,358
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadBronchopulmonary DysplasiaInfectionInfantLungLung InjuryIn VitroLifeMediatingMacrophageLung DiseasesInjuryPreventInflammationInflammatory ResponseCohortNeonateBacteriaLung InflammationResearch PersonnelGenital SystemExhibitsChronicMycoplasma
Grant awards (38)
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection$610,630
R01 · FY2023 · AI
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection$610,630
R01 · FY2022 · AI
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection$610,630
R01 · FY2021 · AI
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection$610,630
R01 · FY2020 · AI
PCTC Administrative Coordinating Center$1,184,212
U24 · FY2019 · HL
PCTC Administrative Coordinating Center$1,135,110
U24 · FY2019 · HL
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection$610,630
R01 · FY2019 · AI
PCTC Administrative Coordinating Center$1,145,433
U24 · FY2018 · HL
Azithromycin To Prevent BPD In Ureaplasma-Infected Preterms$519,779
R01 · FY2018 · HD · contact PI
Azithromycin To Prevent BPD In Ureaplasma-Infected Preterms$679,004
R01 · FY2017 · HD · contact PI
PCTC Administrative Coordinating Center$526,791
U24 · FY2017 · HL
PCTC Administrative Coordinating Center$537,848
U24 · FY2016 · HL
Azithromycin to prevent BPD in ureaplasma-infected preterms.$567,292
R01 · FY2015 · HD · contact PI
Azithromycin to prevent BPD in ureaplasma-infected preterms.$127,500
R01 · FY2015 · HD · contact PI
Azithromycin to prevent BPD in ureaplasma-infected preterms.$571,913
R01 · FY2014 · HD · contact PI
Azithromycin to prevent BPD in ureaplasma-infected preterms.$570,381
R01 · FY2013 · HD · contact PI
Non-invasive neonatal respiration monitor$246,743
R41 · FY2013 · HD
Effect of Lactobacillus GG on gut permeability and microbiome in VLBW neonates$221,109
R34 · FY2013 · AT · contact PI
Azithromycin to prevent BPD in ureaplasma-infected preterms.$597,460
R01 · FY2012 · HD · contact PI
Effect of Lactobacillus GG on gut permeability and microbiome in VLBW neonates$303,930
R34 · FY2012 · AT
Non-invasive neonatal respiration monitor$248,614
R41 · FY2012 · HD
Noninvasive neonatal glucose monitor$230,825
R41 · FY2012 · HD
Azithromycin to prevent BPD in ureaplasma-infected preterms.$622,943
R01 · FY2011 · HD · contact PI
Role of TLR Signaling in Ureaplasma-Mediated Neonatal Lung Injury$371,250
R01 · FY2011 · HL · contact PI
Noninvasive neonatal glucose monitor$232,010
R41 · FY2011 · HD
Effect of Lactobacillus GG on gut permeability and microbiome in VLBW neonates$153,500
R34 · FY2011 · AT
Role of TLR Signaling in Ureaplasma-Mediated Neonatal Lung Injury$371,250
R01 · FY2010 · HL · contact PI
Role of Intrauterine Ureaplasma-Infection in BPD Pathogenesis$185,625
R21 · FY2010 · HD · contact PI
Role of TLR Signaling in Ureaplasma-Mediated Neonatal Lung Injury$371,250
R01 · FY2009 · HL · contact PI
Role of Intrauterine Ureaplasma-Infection in BPD Pathogenesis$225,000
R21 · FY2009 · HD · contact PI
Azithromycin to prevent BPD in Ureaplasma-infected Preterms: Single Dose PK study$97,500
R21 · FY2009 · HD · contact PI
Role of TLR Signaling in Ureaplasma-Mediated Neonatal Lung Injury$359,125
R01 · FY2008 · HL · contact PI
Azithromycin to prevent BPD in Ureaplasma-infected Preterms: Single Dose PK study$182,758
R21 · FY2008 · HD · contact PI
Role of TLR Signaling in Ureaplasma-Mediated Neonatal Lung Injury$355,730
R01 · FY2007 · HL · contact PI
Azithromycin to prevent BPD in Ureaplasma-infected Preterms: Single Dose PK study$228,137
R21 · FY2007 · HD · contact PI
Determinants of Ureaplasma-mediated neonatal lung injury$148,500
R01 · FY2003 · HL
Determinants of Ureaplasma-mediated neonatal lung injury$68,310
R01 · FY2003 · HL
Determinants of Ureaplasma-mediated neonatal lung injury$148,500
R01 · FY2002 · HL